Trial Profile
A Single-center, Uncontrolled, Open-label Clinical Trial Evaluating the Pharmacokinetic Characteristics and Safety of Aripiprazole IM Depot in Chinese Patients With Schizophrenia After Multi-dose Administration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Aripiprazole
- Indications Schizophrenia
- Focus Pharmacokinetics
- 16 Jan 2020 Status changed from recruiting to completed.
- 20 Feb 2019 Planned End Date changed from 1 Apr 2019 to 1 Jul 2019.
- 20 Feb 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Jul 2019.